Fas Ligand (CD95L) and Cancer Gene Therapy

被引:0
|
作者
Gary J. Nabel
机构
[1] National Institutes of Health,
[2] Vaccine Research Center,undefined
关键词
D O I
10.1038/70149
中图分类号
学科分类号
摘要
引用
收藏
页码:25 / 25
相关论文
共 50 条
  • [21] Fas ligand (CD95L) induction in human lymphocytes by the apoptosis-inducing mistletoe lectins
    Büssing, A
    Stein, GM
    Vervecken, W
    Pfüller, U
    Schietzel, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S358 - S358
  • [22] IL-2 induces Fas ligand Fas (CD95L/CD95) cytotoxicity in CD8(+) and CD4(+) T lymphocyte clones
    Esser, MT
    Dinglasan, RD
    Krishnamurthy, B
    Gullo, CA
    Graham, MB
    Braciale, VL
    JOURNAL OF IMMUNOLOGY, 1997, 158 (12): : 5612 - 5618
  • [23] Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells
    Shimizu, M
    Takeda, Y
    Yagita, H
    Yoshimoto, T
    Matsuzawa, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (03) : 143 - 148
  • [24] Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells
    Motomu Shimizu
    Yasutaka Takeda
    Hideo Yagita
    Takayuki Yoshimoto
    Akio Matsuzawa
    Cancer Immunology, Immunotherapy, 1998, 47 : 143 - 148
  • [25] Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: Relationship with neuronal cell death and inflammatory mediators
    Grosjean, M. B.
    Lenzlinger, P. M.
    Stahel, P. F.
    Yatsiv, I.
    Shohami, E.
    Trentz, O.
    Kossmann, T.
    Morganti-Kossmann, M. C.
    HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (03) : 235 - 250
  • [26] Functional Fas ligand (FasL, CD95L) expression on primary human keratinocytes is modulated by different cytokines
    Arnold, R
    Seifert, M
    Volk, HD
    Asadullah, K
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 663 - 667
  • [27] Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis:: An analysis of haplotype and gene-gene interaction
    Lai, HC
    Lin, WY
    Lin, YW
    Chang, CC
    Yu, MH
    Chen, CC
    Chu, TY
    GYNECOLOGIC ONCOLOGY, 2005, 99 (01) : 113 - 118
  • [29] CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies
    J Sträter
    H Walczak
    C Hasel
    I Melzner
    F Leithäuser
    P Möller
    Cell Death & Differentiation, 2001, 8 : 273 - 278
  • [30] CD95 ligand (CD95L) immunohistochemistry:: a critical study on 12 antibodies
    Sträter, J
    Walczak, H
    Hasel, C
    Melzner, I
    Leithäuser, F
    Möller, P
    CELL DEATH AND DIFFERENTIATION, 2001, 8 (03): : 273 - 278